Marchex, Inc.
NASDAQMarchex heads into the post-earnings session with a Q1 miss on both revenue and earnings, but a $10 million strategic funding deal with Archenia adds a complicating wrinkle to what would otherwise be a clean bearish setup. The headline numbers disappointed. Adjusted EPS came in at -$0.03 against a -$0.01 consensus estimate. Revenue landed at $10.62 million, short of the $10.89…
Snapshot as of 14 May 2026
Marchex heads into the post-earnings session with a Q1 miss on both revenue and earnings, but a $10 million strategic funding deal with Archenia adds a complicating wrinkle to what would otherwise be a clean bearish…
MCHX heads into its Q1 2026 earnings today with short sellers retreating — a notable setup for a micro-cap AI-powered advertising analytics name priced at $1.59. The clearest signal in the positioning data is that…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MCHX — free to start on ORTEX.
Sign up for free →Open MCHX on ORTEX